.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Medtronic
Accenture
Express Scripts
Julphar
Cipla
Novartis
Boehringer Ingelheim
AstraZeneca

Generated: July 21, 2017

DrugPatentWatch Database Preview

NEBIVOLOL HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Nebivolol Hydrochloride, and what generic Nebivolol Hydrochloride alternatives are available?

Nebivolol Hydrochloride is a drug marketed by Glenmark Pharms Ltd, Indchemie Health, Alkem Labs Ltd, Amerigen Pharms Ltd, and Watson Labs Inc. and is included in five NDAs.

The generic ingredient in NEBIVOLOL HYDROCHLORIDE is nebivolol hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the nebivolol hydrochloride profile page.

Summary for Tradename: NEBIVOLOL HYDROCHLORIDE

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list1
Bulk Api Vendors: see list83
Clinical Trials: see list2,323
Patent Applications: see list1,467
Drug Prices:see details
DailyMed Link:NEBIVOLOL HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: NEBIVOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd
NEBIVOLOL HYDROCHLORIDE
nebivolol hydrochloride
TABLET;ORAL203821-001May 25, 2017DISCNNoNo► Subscribe► Subscribe
Watson Labs Inc
NEBIVOLOL HYDROCHLORIDE
nebivolol hydrochloride
TABLET;ORAL203683-002Nov 27, 2015DISCNNoNo► Subscribe► Subscribe
Indchemie Health
NEBIVOLOL HYDROCHLORIDE
nebivolol hydrochloride
TABLET;ORAL203828-003Jul 29, 2015DISCNNoNo► Subscribe► Subscribe
Glenmark Pharms Ltd
NEBIVOLOL HYDROCHLORIDE
nebivolol hydrochloride
TABLET;ORAL203821-004May 25, 2017DISCNNoNo► Subscribe► Subscribe
Alkem Labs Ltd
NEBIVOLOL HYDROCHLORIDE
nebivolol hydrochloride
TABLET;ORAL203741-004Jun 24, 2015DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Moodys
Dow
Teva
Accenture
Daiichi Sankyo
US Army
Covington
UBS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot